Monash IVF Group Limited (ASX: MVF) - ETF Exposure

- Current share price for MVF : $0.710

Monash IVF Group Limited (MVF) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It provides human fertility services and is one of the providers of Assisted Reproductive Services (ARS) which is the component of fertility care in Australia and South East Asia. ARS encompass a range of techniques used to assist patients experiencing infertility to achieve a clinical pregnancy including reproductive genetic services. In addition, the Group is a provider of women's imaging services.

MVF General Information ⁺

ASX Code	MVF
Website	N/A
Industry/Sector	Health Care Facilities
Market Cap ($M)	276
MVF Share Price	$0.710
Day High	$0.720
Day Low	$0.710
Last Close	$0.710
MVF Share Price Movement	- ( No change )

Prices as at 16:40, 27 Oct 2026

⁺Security prices are delayed by at least 20 minutes and are indicative only.

Already own an Australian ETF? You may already have meaningful exposure to MVF

Monash IVF Group Limited (MVF) is held across 7 ETFs spanning strategies that include health care facilities exposure . Its weighting in those funds means performance can have an outsized influence - when MVF moves, funds like DAVA, DACE and PGA1 that hold it can move with it.

For more concentrated exposure, ETFs such as DAVA (Dimensional Australian Value Trust - Active ETF) allocate about 0% to MVF , while the average exposure across all 7 ETFs that hold it is around 0% .

Top ETF holdings

Dimensional Australian Value Trust - Active ETF (DAVA) ~ 0%
Dimensional Australian Core Equity (Managed Fund) (DACE) ~ 0%
Plato Global Alpha Fund Complex ETF (PGA1) ~ 0%

Last updated: ETF data and holdings as at 23 October 2026

Own MVF directly or through an ETF?

How does holding Monash IVF Group Limited (MVF) shares directly compare to ETFs that include it?

	MVF Direct	DAVA ASX	DACE ASX	PGA1 ASX
Holdings	1 company	183 holdings	501 holdings	2,740 holdings
MVF Weight	100%	0%	0%	0%
Diversification	Single Stock	Broad	Broad	Broad
Annual Cost	Brokerage only	0.34% p.a.	0.28% p.a.	0.85% p.a.
Approx. Yield	3.5%	6.58%	3.18%	-
Star Ratings	-

Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not MVF's direct yield. Annual cost uses each ETF's MER.

MVF Exposure on $10,000 investment

How a $10,000 investment in Monash IVF Group Limited (MVF) one week ago compares with ETFs that hold it.

Security	Investment type	Current price	7-day price movement	Dollar change	Value today
Monash IVF Group Limited (MVF)	Direct share	$0.710	-0.70%	-$70	$9,930
Dimensional Australian Value Trust - Active ETF (DAVA)	Equity - Australia Strategy	$31.600	0.25%	+$25	$10,025
Dimensional Australian Core Equity (Managed Fund) (DACE)	Equity - Australia Strategy	$18.560	0.05%	+$5	$10,005
Plato Global Alpha Fund Complex ETF (PGA1)	Equity - Global Strategy	$15.110	-0.92%	-$92	$9,908

Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.

Monash IVF Group Limited (MVF) ETFs

7 ETFs hold Monash IVF Group Limited (MVF).

ETF	MVF Weight	MER	Yield
Dimensional Australian Value Trust - Active ETF (DAVA)	0%	0.34%	6.58%
Dimensional Australian Core Equity (Managed Fund) (DACE)	0%	0.28%	3.18%
Plato Global Alpha Fund Complex ETF (PGA1)	0%	0.85%	-

View all 7 ETFs

Monash IVF Group Limited (MVF) Upcoming Dividends & Yields

Distribution Type	Dividend	Franking	Ex-dividend date	Payment date	Current Price⁺	Price 7D Avg	Dividend Yield
HFResult	1.3¢	100%	3 Sep 2026	15 Oct 2026	-	-	-
Result	1.2¢	100%	4 Mar 2026	10 Apr 2026	-	-	-
Result	2.6¢	100%	6 Mar 2025	11 Apr 2025	-	-	-

See all dividends from Monash IVF Group Limited (MVF) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Monash IVF Group Limited (MVF) price-sensitive announcements

MVF - MVF FY26 Investor Presentation

Monash IVF Group Limited’s FY26 Investor Presentation outlines a year of two halves, with

Monash IVF Group Limited (MVF)
31 Aug 2026 | 8:28 AM

MVF - MVF FY26 Results Announcement

Monash IVF Group Limited’s FY26 results announcement reported revenue of $269.5 million, U

Monash IVF Group Limited (MVF)
31 Aug 2026 | 8:16 AM

MVF - MVF FY26 Appendix 4E and Financial Report

Monash IVF Group Limited’s FY26 Appendix 4E and Financial Report for the year ended 30 Jun

Monash IVF Group Limited (MVF)
31 Aug 2026 | 8:14 AM

MVF - FY2026 Results release postponed to 31 August 2026

Monash IVF Group Limited announced the postponement of its FY2026 financial results releas

Monash IVF Group Limited (MVF)
24 Aug 2026 | 8:08 AM

Monash IVF Group Limited (MVF) Recent ASX Announcements

Company	Sector	Market Cap ($m)	Headline	Release date/time⁺	Price at release⁺	Current price⁺	Gain/Loss
Monash IVF Group Limited (MVF) ORDINARY FULLY PAID	Health Care	$277	Appendix 3Z	26 Oct 2026 9:09AM	$0.715	$0.710	fallen by 0.70%
Monash IVF Group Limited (MVF) ORDINARY FULLY PAID	Health Care	$277	Director resignation and withdrawal of AGM resolution 3c	26 Oct 2026 9:07AM	$0.715	$0.710	fallen by 0.70%
Monash IVF Group Limited (MVF) ORDINARY FULLY PAID	Health Care	$277	Notice of 2026 AGM, Proxy Form and Access Letter	23 Oct 2026 8:57AM	$0.730	$0.710	fallen by 2.74%
Monash IVF Group Limited (MVF) ORDINARY FULLY PAID	Health Care	$277	Annual Report to shareholders	23 Oct 2026 8:54AM	$0.730	$0.710	fallen by 2.74%
Monash IVF Group Limited (MVF) ORDINARY FULLY PAID	Health Care	$277	Appointment of CFO	9 Oct 2026 9:11AM	$0.750	$0.710	fallen by 5.33%
Monash IVF Group Limited (MVF) ORDINARY FULLY PAID	Health Care	$277	Important Dates for Shareholders	24 Sep 2026 4:46PM	$0.750	$0.710	fallen by 5.33%

MVF Financial Summary

Year to Jun	NPAT	EPS	EPS chg (%)	PER	DPS	Yield (%)	Franking (%)
2028F	C2	$5.30	14.10%	13.50	3.10	4.30%	0.0%
2027F	C2	$4.60	77.60%	15.40	2.40	3.40%	0.0%
2026A	$10.99	$2.60	-59.90%	27.90	2.50	3.50%	100.0%

MVF Peer Comparison

Company	Mkt Cap	EPS Growth (%)			P/E (%)			Dividend Yield (%)
Company	Mkt Cap	2026 A	2027 F	2028 F	2026 A	2027 F	2028 F	2026 A	2027 F	2028 F
Monash IVF Group Limited (MVF)	$277M	-0.5991	0.7761	0.1413	27.4131	15.4348	13.5238	3.52%	3.38%	4.30%
Regis Healthcare Limited (REG)	$1,440M	0.2575	-0.2456	0.1012	21.3740	28.3333	25.7297	3.87%	3.17%	3.49%
Ramsay Health Care Limited (RHC)	$12,682M	-0.0201	0.1363	0.1419	35.6869	31.4051	27.5030	1.66%	1.87%	2.15%

MVF Directors

Name	Position	Start Date
Dr Richard Charles Henshaw	Executive Director	30 Apr 2014
Mr Richard Hugh Davis	Non-Executive Chairman, Non-Executive Director	4 Jun 2014
Ms Zita Peach	Non-Executive Director	12 Oct 2016
Dr Dwayne Crombie	Non-Executive Director	24 Nov 2025
Ms Catherine (Cathy) Ann Aston	Non-Executive Director	26 Feb 2024
Mr Gerd Schenkel	Non-Executive Director	1 Sep 2026
Ms Victoria Atkinson	Non-Executive Director	5 Jan 2026
Ms Catherine Jane West	Non-Executive Director, Non-Executive Chairman	8 Sep 2020

Monash IVF Group Limited (MVF) Changes in Directors' Interest & Trades

Date of change	Director	Buy/Sell	Security Type	Qty	Trade Price	Value
29 Dec 2025	ASTON, Catherine (Cathy)	Sell	Indirect Shares	75,000	$0.719	$53,928.710
16 Sep 2024	ASTON, Catherine (Cathy)	Buy	Direct Shares	2,000	$1.211	$2,422.597
16 Sep 2024	ASTON, Catherine (Cathy)	Buy	Indirect Shares	75,000	$1.211	$90,847.403

See all changes in directors' interest & trades for Monash IVF Group Limited (MVF) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

MVF Management

Name	Position
Johannes Lagerwij	Asia Managing Director
Peggy North	Chief Corporate Shared Services Officer
Tedd Fuell	Chief Governance and Risk Officer
Thierry Panthier	Chief Information Officer
Rebecca Redden	Chief Operating Officer
Deirdre Zander Fox	Chief Scientific Officer
Rebecca Dean	Company Secretary,General Counsel
Luk Rombauts	Group Medical Director

MVF Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Monash IVF Group Limited (MVF). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding	Name
37,767,969 (9.69%)	Washington H. Soul Pattinson and Company Limited
24,375,402 (6.26%)	Argo Investments Limited
19,725,471 (5.06%)	Regal Funds Management Pty Ltd

MVF Calendar of Events

Date	Event
22 October 2027	Report (Annual)
22 October 2027	Report (Prelim)
30 August 2027	Report (Annual)
30 August 2027	Report (Prelim)
25 February 2027	Report (Interim)
26 November 2026	AGM

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.

What our members say about us